| 序号 | 股票代码 | 股票名称 | 机构名称 | 变动方向 | 变动股份数(股) | 变动后数量(股) | 变动后持股率 | 公布日期 |
| 1 | 02216 | 堃博医疗-B | LAKE BLEU CAPITAL (Hong Kong) LIMITED |
减持 | -4.00万 | 2630.93万 | 4.99% | 2024-02-28 |
| 2 | 02216 | 堃博医疗-B | Xin Nuo Tong Investment Limited |
减持 | -681.66万 | 4226.15万 | 8.02% | 2024-01-17 |
| 3 | 02216 | 堃博医疗-B | Broncus Biomedical Limited |
减持 | -2195.67万 | 2178.52万 | 4.13% | 2023-11-17 |
| 4 | 02216 | 堃博医疗-B | Dinova Capital Limited |
减持 | -2195.67万 | 2616.52万 | 4.96% | 2023-11-17 |
| 5 | 02216 | 堃博医疗-B | Dinova Capital Limited |
增持 | 92.00万 | 4812.20万 | 9.13% | 2023-11-17 |
| 6 | 02216 | 堃博医疗-B | Dinova Healthcare Gamma Fund (USD), L.P. |
减持 | -2195.67万 | 2178.52万 | 4.13% | 2023-11-17 |
| 7 | 02216 | 堃博医疗-B | Dinova Venture Partners GP III, L.P. |
减持 | -2195.67万 | 2616.52万 | 4.96% | 2023-11-17 |
| 8 | 02216 | 堃博医疗-B | Dinova Venture Partners GP III, L.P. |
增持 | 92.00万 | 4812.20万 | 9.13% | 2023-11-17 |
| 9 | 02216 | 堃博医疗-B | Qiming Corporate GP IV, Ltd. |
增持 | 613.32万 | 8754.60万 | 16.61% | 2023-11-17 |
| 10 | 02216 | 堃博医疗-B | Qiming GP IV, L.P. |
增持 | 594.54万 | 8735.82万 | 16.57% | 2023-11-17 |
| 11 | 02216 | 堃博医疗-B | Qiming Venture Partners IV, L.P. |
增持 | 594.54万 | 8735.82万 | 16.57% | 2023-11-17 |
| 12 | 02216 | 堃博医疗-B | Xin Nuo Tong Investment Limited |
减持 | -2195.67万 | 4983.52万 | 9.45% | 2023-11-17 |
